Xiaomi Tong PhD

Xiaomi Tong is the Senior Consultant of Regulatory Affairs & Quality at Tunnell Government Services, Inc., Bethesda, Maryland, United States. Xiaomi will be responsible for Process Development, Product Realization, Regulatory and Clinical, with special emphasis on the Company’s Ebola vaccine program. Xiaomi has extensive experience in biopharmaceutical product development, manufacturing, and commercialization. Previously, she served as Vice President of Advanced Development and Manufacturing at Emergent BioSolutions Corporation and Principal Investigator for Emergent’s Centers for Innovation in Advanced Development and Manufacturing (ADM), a public-private partnership with the U.S. Department of Health and Human Services responsible for developing and manufacturing vaccines and other medical countermeasures against pandemic influenza, and biological, chemical, radiological and nuclear threats. She also served as Vice President of Regulatory Affairs, responsible for the development and implementation of global regulatory strategies. Prior to joining Emergent, Xiaomi served as Senior Regulatory Affairs Representative at DynPort Vaccine Company and Product Team Leader and Manufacturing Manager at Aventis Pasteur (now Sanofi Pasteur) of the commercial viral vaccines (influenza vaccine, yellow fever vaccine, and mumps skin test antigen).

She received her Ph.D. in Bioengineering from the University of Utah and her bachelor’s degree in Biomedical Engineering from Shanghai Jiao Tong University.